• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. TRULIANT; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. TRULIANT; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, Back to Search Results
Model Number TRULIANT PS CEM FEM PS CEM LEFT SZ 5
Device Problem Loss of or Failure to Bond (1068)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 04/28/2022
Event Type  Injury  
Event Description
It was reported via an exactech truliant knee clinical study, that a 64 yo male patient, initial left tka on (b)(6) 2019, underwent a revision procedure on (b)(6) 2022, approximately 2 years 7 months post the initial procedure.Date of onset, (b)(6) 2022.Femoral loosening and recalled poly resulted in the revision of the femoral and tibial components.Outcome indicates resolved on the date of the procedure.No devices returning due to clinical study guidelines.No further information.
 
Manufacturer Narrative
Concomitant medical products: product id: 02-022-35-5010 - truliant tib imp ps insert sz 5 10mm, (b)(4), serial number (b)(4) is confirmed to have been packaged in a vacuum bag that does not contain evoh.02-022-45-5040 - truliant tib fit tray cem sz 5f / 4t, (b)(4), 200-07-35 - advanced patella 35mm 3 peg implant, (b)(4).Additional information, including the product investigation, will be submitted within 30 days of receipt.
 
Manufacturer Narrative
H3: the femoral loosening reported is most likely the result of either a weakened biologic integration of the femoral component at the bone-implant interface or mechanical loss of fixation at the cement-implant interface.However, the failure cannot be confirmed as the device was not returned for investigation, pre-revision x-rays were unable to be obtained, and potential contributions from the type of cement used, cementing technique, or environmental conditions in the operating room at the time of implantation cannot be determined from the provided information.Inclusion of the implanted polyethylene tibial insert in the packaging recall may have been a contributing factor to the reported revision.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRULIANT
Type of Device
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED,
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer (Section G)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer Contact
kate jacobson
3523771140
MDR Report Key16196124
MDR Text Key307604728
Report Number1038671-2023-00015
Device Sequence Number1
Product Code JWH
UDI-Device Identifier10885862314475
UDI-Public10885862314475
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K170240
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date 11/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTRULIANT PS CEM FEM PS CEM LEFT SZ 5
Device Catalogue Number02-020-11-0250
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/24/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-0023-2022
Patient Sequence Number1
Treatment
SEE H10
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexMale
Patient Weight80 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-